Xcout Intel
Abilita Therapeutics
Abilita Therapeutics, Inc. is a privately held biotechnology company founded in 2014 and focused on redefining therapeutics. The company is headquartered in San Diego, California.
Subscribe to see Abilita Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Abilita Therapeutics at a glance
Abilita Therapeutics is a biotech company headquartered in United States. Its most recent funding round, Series A, closed in February 2023. Xcout tracks 6 named people at Abilita Therapeutics, including Jim Schmidt (Chief Financial Officer).
Abilita Therapeutics leadership
- Jim SchmidtChief Financial Officer
- Matthew RitterChief Business Officer
- Arshan AmiriGeneral Counsel
- Mauro MileniFounder & Chief Executive Officer
- Christopher B. RothSenior Vice President, Research
- Daniel BradburyDirector of the Board
Abilita Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | Undisclosed | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Abilita Therapeutics competitors
A few of Abilita Therapeutics's closest competitors — see the full list of competitors and alternatives →
Adcentrx Therapeutics is a privately held biotechnology company founded in 2021 that focuses on accelerating advanced medical treatments. Its research headquarters are located in San Diego, California.
Autobahn Therapeutics, Inc. is a privately held biopharmaceutical company with its corporate office and headquarters located in San Diego, California, focused on restoring hope for patients.
Autobahn Therapeutics is a biotechnology company headquartered in San Diego, California, focused on developing restorative treatments in the medical sector.
Ablytx is a biotechnology company headquartered in San Diego and Del Mar, California. The company pioneers a class of medicines designed to selectively remove disease-driving proteins from cell surfaces.
Synthorx, Inc., founded in 2014, is a biotechnology company headquartered in La Jolla, California, that engineered expanded genetic alphabet technologies to discover and develop novel protein therapeutics.
Protalys Therapeutics, Inc. is a private drug discovery and development company headquartered in San Diego, California, operating within the therapeutics and drug pipeline sector.
Get Abilita Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Abilita Therapeutics in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access